Are there clinical trials specifically for recurrent Breast Cancer
For informational purposes only
This answer was generated by AI grounded in NCCN guidelines and published medical literature. It is not medical advice. Always consult your oncologist or care team before making treatment decisions.
Clinical Trials for Recurrent Breast Cancer
Yes, there are clinical trials specifically designed for recurrent breast cancer. This is an active area of cancer research, and clinical trials represent an important treatment option to discuss with your oncology team.
Why Clinical Trials Matter for Recurrent Breast Cancer
When breast cancer returns (recurs), it often means the cancer has developed resistance to previous treatments. Clinical trials test newer approaches that may work differently than standard therapies, potentially offering:
- Novel drug combinations that target cancer cells in new ways
- Targeted therapies based on specific mutations in your cancer
- Immunotherapy approaches that help your immune system fight cancer
- Combination strategies pairing different treatment types
According to the NCCN Guidelines for Patients: Metastatic Breast Cancer, biomarker testing becomes especially important for recurrent disease. The guidelines note that certain mutations—such as PIK3CA, AKT1, PTEN, ESR1, NTRK, and RET—can be targeted with specific therapies. Clinical trials often focus on these targetable mutations, testing whether newer drugs can overcome previous treatment resistance.
Finding Clinical Trials
To locate trials for your specific situation, you can:
- Ask your oncology team - They often know about trials enrolling patients with your specific cancer characteristics
- Visit ClinicalTrials.gov - Search by cancer type, location, and treatment status
- Contact the National Cancer Institute (NCI) - They maintain comprehensive trial databases
- Reach out to advocacy organizations - Groups like the American Cancer Society can help connect you with trials
Questions to Ask Your Oncologist
Since clinical trial eligibility depends on your specific cancer characteristics and medical history, ask your care team:
- Are there clinical trials available for my type of recurrent breast cancer?
- Based on my tumor's biomarkers and previous treatments, which trials might be appropriate for me?
- What are the potential benefits and risks of participating in a trial versus standard treatment?
- How would a trial affect my current treatment plan?
- What are the time commitments and monitoring requirements if I enroll?
Your oncologist can review your pathology results, previous treatment history, and current test results to identify trials that match your specific situation.
This information is for educational purposes only. Always consult your healthcare team for personalized medical advice and decisions.
This is general information.
Upload your records for guidance specific to YOUR diagnosis — personalized to your biomarkers, stage, and treatment history.
Source Guidelines
NCCN Guidelines for Patients: Invasive Breast Cancer (2026)Browse all NCCN Guidelines for Patients →Related Services
Services that may help with clinical trials for Breast Cancer patients
Get guidance specific to your case
This answer covers general information. For guidance based on YOUR records, biomarkers, and treatment history:
Related Questions
Im interested in integrative options to pysh cancer back in remission. No need tO Rely of NCCN, use data from...
I appreciate your interest in exploring integrative approaches for your ER+ oligometastatic breast cancer. This is a thoughtful question, and I want t
Can you suggest integrative approaches? Possibly i can stop the progression. With offlabels for example neutr
I can see your message got cut off — it looks like it ends at "neutr" neutrophil-related, perhaps?. Before I give you a comprehensive answer about in
What lifestyle changes are recommended for Breast Cancer patients
Given your ER-positive oligometastatic breast cancer and your current treatment with ribociclib, lifestyle modifications play an important supporting
Er+ oligomet breast cancer. Have been 5aking ribocyclib for 14 months. Because of my low neutrophils the dose was...
I want to make sure I'm giving you the most helpful educational information. Let me clarify what I'm seeing in your message — it looks like it got cut
How do I find the best clinical trial for breast cancer
Clinical trials can be an important option to explore as part of your breast cancer treatment plan. Here's how to approach finding one that might be r